Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in Europe

O Kirakosyan, M Reimann, A B Andersen, A Bjarnason, Á Bakos, A M Dyrhol-Riise, A M McLaughlin, C Nita, D Pieridou, D Chesov, E V Davidavičienė, G Günther, H Atshemyan, I Muylle, I Solovic, J Bruchfeld, K Manika, L Kuksa, L R Codecasa, M StosicM Skowroński, M J Makek, M Fréchet Jachym, M Knappik, M Santin, N Yatskevich, O Konstantynovska, O Akkerman, P Svetina, P Viiklepp, R Duarte, S Zeynel, T Togonidze, T Vasankari, V Parris, Ş Özkara, C Lange*, T T Brehm

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in Europe'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases